Join us Professional membership
Keep In Touch

Add Your Email:

Latest News

Tocilizumab is not approved by NHS England for GCA on cost grounds

Posted: 11 December 2017

We are very sorry to have to share the news that NICE, the National Institute for Health and Clinical Excellence, has rejected approval of tocilizumab for GCA.

Their decision is open to consultation, and we would like as many GCA patients as possible to comment on their website about this decision.

To find out more, including how to comment on their website, please read Kate Gilbert's post on HealthUnlocked.

The deadline for comments is 4th January, so we don't have long.

See all news entries

Valid XHTML 1.0 Strict Valid CSS!

Site by Desktop Solutions